Insights+: COVID-19 Healthcare News Monthly Updates - September 2020
- Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
- Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease
- PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date
Sept 30, 2020 | Clinical Trial
70. Doctors in Lowell Report Positive Outcomes for Second COVID-19 Patient Treated with Laser Therapy
Sept 29, 2020 | Clinical Trial
69. Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New Antimetabolites
Sept 29, 2020 | Clinical Trial
68. Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19
Sept 28, 2020 | Clinical Trial
67. COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan
Sept 28, 2020 | Clinical Trial
63. INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800
Sept 28, 2020 | Regulatory
62. FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica's itMSC Therapy for COVID-19 Patients
Sept 28, 2020 | Regulatory
61. Preventative Nasal Spray Shown to Reduce Viral Replication by up to 96% in COVID-19 Challenge Study
Sept 28, 2020 | Clinical Trial
60. Parade/Cleveland Clinic 'Healthy Now' Survey Reveals Positive Long-term Effects of COVID-19 Pandemic: Embracing Healthy Lifestyle Changes, Valuing Personal Relationships, Finding Meaning, Remaining Hopeful
Sept 25, 2020 | Clinical Trial
59. Novavax Initiates P-III Study of its COVID-19 Vaccine in the UK
Sept 25, 2020 | Clinical Trial
58. JanOne Successfully Begins Production of JAN101 cGMP Batch for Phase 2b Peripheral Artery Disease (PAD) Trial and Potential Covid-19 Study
Sept 24, 2020 |
57. Influenza or COVID-19? Reliable diagnosis in 75 minutes with new multiplex assay from Abacus Diagnostica
Sept 23, 2020 | Diagnostic
56. J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine
Sept 24, 2020 | Clinical Trial
55. DURECT Corporation Announces First Patient Dosed in Phase 2 Safety and Efficacy Study of DUR-928 in COVID-19 Patients with Acute Liver or Kidney Injury
Sept 23, 2020 | Clinical Trial
54. Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19
Sept 23, 2020 | Collaboration
53. Avigan Shows Promising Results in Treatment of COVID Patients in Japan
Sept 23, 2020 | Clinical Trial
52. FDA Authorizes First Point-of-Care Antibody Test for COVID-19
Sept 23, 2020 | Diagnostic
51. DetectaChem Smartphone-Based COVID-19 Test Advances Through NIH RADx (Rapid Acceleration of Diagnostics) Program
Sept 22, 2020 | DigiHealth
50. FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress
Sept 21, 2020 | Regulatory
49. Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-Go COVID-19 Testing Device
Sept 21, 2020 | Collaboration
48. Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia
Sept 18, 2020 | Clinical Trial
47. Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies
Sept 18, 2020 | Diagnostic
46. Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies
Sept 18, 2020 | Collaboration
45. NRL, NCATS Scientists Develop Method to Safely Study COVID-19, Other Contagious Diseases
Sept 18, 2020 | Clinical Trial
44. Beech Tree Labs selects Curavit Clinical Research for fully virtual COVID-19 clinical trial
Sept 18, 2020 | Clinical Trial
43. HSS Funds Innovative Research on COVID-19
Sept 18, 2020 | Grant
42. Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells
Sept 18, 2020 | Clinical Trial
41. Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Sept 17, 2020 | Clinical Trial
40. Sorrento to Initiate P-I Study of STI-1499 in COVID-19 Positive Patients
Sept 17, 2020 | Clinical Trial
39. CEBINA Reports Positive Findings on the Potency of Azelastine
Sept 17, 2020 | Clinical Trial
38. Seattle AVM Biotechnology Announces Second IND for AVM0703: Clinical Trial Permitted to Treat COVID-19 and Influenza ARDS with its 'supercharged' Version of Dexamethasone
Sept 16, 2020 | Regulatory
37. Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting
Sept 16, 2020 | Clinical Trial
36. Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to Advance Trials with COVID-19 Compliance
Sept 15, 2020 | Clinical Trial
35. FUJIFILM Sonosite and the CHEST Foundation Partner for COVID-19 Research
Sept 15, 2020 | Collaboration
34. BenevolentAI's Platform-Derived Hypothesis for COVID-19 Treatment Validated in US NIAID Randomised Control Trial
Sept 14, 2020 | Clinical Trial
33. Ampion Phase I COVID-19 Patient Trial Results Featured on FOX News
Sept 14, 2020 | Clinical Trial
32. Biotechnology Leader LuminUltra Submits COVID-19 Clinical Diagnostic Testing Kit for Regulatory Authorization in U.S., Canada
Sept 14, 2020 | Diagnostics
31. Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122
Sept 14, 2020 | Diagnostics
30. RECOVERY COVID-19 Phase 3 Trial to Evaluate Regeneron's REGN-COV2 Investigational Antibody Cocktail in the UK
Sept 14, 2020 | Clinical Trial
29. Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
Sept 14, 2020 | Clinical Trial
28. Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine
Sept 14, 2020 | Collaboration
27. Senhwa Reports First eIND Silmitasertib Treated Severe COVID-19 Patient Discharged Following Five Days of Treatment
Sept 11, 2020 | Regulatory
26. Pfizer and BioNTech to Supply 200M Doses of it COVID-19 Vaccine in the EU
Sept 10, 2020 | Collaboration
25. New Study Published in PLOS Medicine Explores Impact of Race, Age & Comorbidities on COVID-19 Mortality
Sept 10, 2020 | Clinical Trial
24. Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial
Sept 09, 2020 | Clinical Trial
23. Bioclinica Partners with Direct Biologics to Provide Interactive Response Technology (IRT) Solution for COVID-19 Study
Sept 09, 2020 | Clinical Trial
22. Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients
Sept 09, 2020 | Clinical Trial
21. The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19
Sept 09, 2020 | Clinical Trial
20. New Head-to-Head Study Demonstrates Equivalency and Accuracy of COVID-19 Rapid Point-of-Care Tests, Despite Different Test Sensitivity Claims
Sept 09, 2020 | Diagnostics
19. DPHARM Presents the Largest Number of Sessions Across R&D on Decentralized Clinical Trials Due to COVID-19
Sept 09, 2020 | Clinical Trial
18. Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19
Sept 08, 2020 | Clinical Trial
17. Celularity Doses First Patient in Clinical Trial Evaluating CYNK-001 in COVID-19 Patients
Sept 08, 2020 | Clinical Trial
16. Co-Diagnostics Enters into Agreement with Arches Research to Expand COVID-19 Testing Services
Sept 08, 2020 | Collaboration
14. CytoSorbents Reports the CytoSorb Therapy in COVID-19 ICU Patients (CTC) Registry Is Actively Enrolling
Sept 08, 2020 | Clinical Trial
13. Ampio Reports Enrollment Completion for IV COVID-19 Clinical Trial & Provides Update on OAK Clinical Trial
Sept 04, 2020 |Clinical Trial
12. DetectaChem Receives FDA EUA Authorization for Mobile COVID-19 Detection Technology
Sept 03, 2020 | DigiHealth
11. Sanofi And GSK Initiate P-I/II Study of COVID-19 Protein-Based Vaccine
Sept 03, 2020 | Clinical Trial
10. Experts at CenExel Clinical Research Sites Tackle COVID-19 Vaccine Testing
Sept 02, 2020 | Clinical Trial
9. ANVISA Authorizes Dompé's REPAVID-19 P-II Study for Treatment of Severe Patients
Sept 02, 2020 | Approval
8. Sanford Health Initiates P-Ib Study of SAB-185 Against COVID-19
Sept 02, 2020 | Clinical Trial
7. Pulmonem Receives Health Canada Approval to Initiate P-III Clinical Study for COVID-19
Sept 02, 2020 | Regulatory
6. AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19
Sept 01, 2020 | Collaboration
5. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19
Sept 01, 2020 | Collaboration
4. AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups
Sept 01, 2020 | Clinical Trial
3. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19
Sept 01, 2020 | Collaboration
2. Aerpio and Quantum Leap Report First Patients Dosing with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-Ill COVID-19 Patients
Sept 01, 2020 | Clinical Trial
1. Rowpar Pharmaceuticals Demonstrate CloSYS Ultra Sensitive Oral Rinse Reduced SARS-CoV-2 Infection
Sept 01, 2020 | Clinical Trial
Related News: Insights+: COVID-19 Healthcare News Monthly Updates August 2020
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com